Endothelial-derived PANoptosis factor IL33 is a potential immunotherapy in breast cancer

iScience 2026 Open access

Read full text

Authors: Yuan Qi, Zehao Li, Lanning Jia, Shuxian Yang, Ziyi Li, Yingpu Li, Sifan Zhang

DOI: 10.1016/j.isci.2026.115722

Cited by: 1

References: 46

Abstract

endothelial cells in shaping BC immunity and prognosis.

IL-33 ST2 and ILC Pathways Inflammasome and immune disorders Immune cells in cancer

References 46